Varicella-Zoster Virus Infection of Neurons Derived from Neural Stem Cells.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 03 2021
Historique:
received: 29 01 2021
revised: 25 02 2021
accepted: 12 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 13 8 2021
Statut: epublish

Résumé

Varicella-Zoster virus (VZV) is a human herpesvirus that causes varicella (chickenpox) as a primary infection, and, following a variable period of ganglionic latency in neurons, it reactivates to cause herpes zoster (shingles). An analysis of VZV infection in cultures of neural cells, in particular when these have been obtained from induced pluripotent stem cells (iPSCs) or neural stem cells consisting of highly purified neuronal cultures, has revealed much data that may be of neurobiological significance. Early studies of VZV infection of mature cultured neural cells were mainly descriptive, but more recent studies in homogeneous neural stem cell cultures have used both neuronal cell markers and advanced molecular technology. Two general findings from such studies have been that (a) VZV infection of neurons is less severe, based on several criteria, than that observed in human fibroblasts, and (b) VZV infection of neurons does not lead to apoptosis in these cells in contrast to apoptosis observed in fibroblastic cells. Insights gained from such studies in human neural stem cells suggest that a less severe initial lytic infection in neurons, which are resistant to apoptosis, is likely to facilitate a pathological pathway to a latent state of the virus in human ganglia.

Identifiants

pubmed: 33804210
pii: v13030485
doi: 10.3390/v13030485
pmc: PMC7999439
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS Pathog. 2013;9(8):e1003512
pubmed: 23935496
J Virol. 2011 Jul;85(13):6678-86
pubmed: 21525352
J Virol. 2014 May;88(10):5877-80
pubmed: 24600007
Arch Virol. 1978;56(1-2):105-17
pubmed: 204267
Virology. 2014 Jun;458-459:1-3
pubmed: 24928033
J Virol. 2000 Dec;74(24):11893-8
pubmed: 11090189
Viruses. 2018 Nov 02;10(11):
pubmed: 30400213
J Neurovirol. 2013 Feb;19(1):75-81
pubmed: 23233078
Nat Rev Dis Primers. 2015 Jul 02;1:15016
pubmed: 27188665
J Virol. 1996 May;70(5):2789-96
pubmed: 8627753
J Virol. 2012 Sep;86(18):10203-6
pubmed: 22740396
J Virol. 2015 Oct 21;90(1):379-91
pubmed: 26491149
PLoS One. 2012;7(12):e53010
pubmed: 23285249
Virology. 2013 Sep 1;443(2):285-93
pubmed: 23769240
J Virol. 2003 Jun;77(12):6660-5
pubmed: 12767985
Viruses. 2019 Jan 26;11(2):
pubmed: 30691086
J Virol. 2012 Mar;86(6):3211-8
pubmed: 22238301
J Neurovirol. 2020 Aug;26(4):482-495
pubmed: 32495195
Cleve Clin J Med. 2007 Jul;74(7):489-94, 496, 498-9 passim
pubmed: 17682626
J Neurovirol. 2020 Jun;26(3):330-337
pubmed: 32125664
J Virol. 2011 Mar;85(5):2276-87
pubmed: 21177814
Ann Neurol. 1994 May;35(5):530-3
pubmed: 8179298
Neurology. 2015 May 12;84(19):1948-55
pubmed: 25695965
BMC Neurosci. 2007 Nov 30;8:104
pubmed: 18053121
Virus Res. 2019 Dec;274:197773
pubmed: 31614167
Virology. 1986 Jul 30;152(2):384-99
pubmed: 2425480
Neurology. 2011 Feb 1;76(5):416-7
pubmed: 21282588
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4658-62
pubmed: 9539794
Viruses. 2013 Sep 04;5(9):2106-15
pubmed: 24008377
Virology. 1990 Dec;179(2):834-44
pubmed: 2173263
J Virol. 2011 Jul;85(13):6220-33
pubmed: 21525353
Brain. 1983 Mar;106 (Pt 1):101-19
pubmed: 6831193
J Gen Virol. 2015 Jul;96(Pt 7):1581-602
pubmed: 25794504
Virology. 1994 Dec;205(2):558-62
pubmed: 7975257
Glia. 2021 Jan;69(1):201-215
pubmed: 32818313
J Virol. 2013 Sep;87(17):9643-8
pubmed: 23804641
PLoS One. 2013;8(1):e51570
pubmed: 23382806
J Virol. 2017 Dec 14;92(1):
pubmed: 29046461
J Neurovirol. 2010 Nov;16(6):411-8
pubmed: 20874010
Lab Invest. 1980 Oct;43(4):342-51
pubmed: 6160316
Nat Commun. 2018 Mar 21;9(1):1167
pubmed: 29563516
Am J Ophthalmol. 2018 Mar;187:51-60
pubmed: 29294312
J Virol. 2017 Nov 30;91(24):
pubmed: 29021397

Auteurs

Peter G E Kennedy (PGE)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow G61 1QH, Scotland, UK.

Trine H Mogensen (TH)

Department of Infectious Diseases, Aarhus University Hospital, 8000 Aarhus, Denmark.
Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH